June 11, 2020
6 min watch
Save
VIDEO: Dextenza effective against ocular allergy
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.
In this video perspective from the virtual American Society of Cataract and Refractive Surgery meeting, Steven M. Silverstein, MD, discusses the results of a phase 3 study of Dextenza for the treatment of allergic conjunctivitis.
The study found the dexamethasone ophthalmic insert 0.4 mg from Ocular Therapeutix was effective at treating the signs and symptoms of seasonal and perennial ocular allergies.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Read more about
You've successfully added to your alerts. You will receive an email when new content is published.
Click Here to Manage Email Alerts
Click Here to Manage Email Alerts
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.